FDAnews Drug Daily Bulletin

THERAPEUTICS REPORTS FIRST QUARTER 2006

May 3, 2006
A A

Sirna Therapeutics, Inc. RNAI today reported financial results for the first quarter ended March 31, 2006. For the quarter ended March 31, 2006, Sirna reported a net loss of $8.0 million, or $0.13 per share, compared to a net loss of $8.0 million, or $0.19 per share, for the same period in 2005. MSN Money (http://news.moneycentral.msn.com/provider/providerarticle.asp?feed=PR&Date=20060502&ID=5686013)